The global market for Psychedelics is whoever is being treated for depression, anxiety, eating disorders, epilepsy, PTSD to name a few, which is roughly 20% of the 1st world population.
There are currently over a 100 clinical trials worldwide in Psychedelics in various stages. Most are showing up to 70% remission, where antidepressants at best are 30%.
America already have fast tracked psychedelics into the community through the FDA break through therapies, that is therapies that show significant improvement in symptoms. Australia also has a similar scheme.
To have a debate both parties need to be talking about a subject they know about. I know about Psychedelic Assist Therapy.
It's obvious you do not.
- Forums
- ASX - By Stock
- CPH
- Creso Pharma - A Global Cannabis and Psychedelics Powerhouse in the Making
Creso Pharma - A Global Cannabis and Psychedelics Powerhouse in the Making, page-46
-
-
- There are more pages in this discussion • 329 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)